Hepatic insulin expression improves glycemic control in type 1 diabetic rats (Q43588795)

25 November 2017

Hepatic insulin expression improves glycemic control in type 1 diabetic rats (English)

1 reference

25 November 2017

1 reference

Dong H

1

1 reference

25 November 2017

Morral N

2

1 reference

25 November 2017

McEvoy R

3

1 reference

25 November 2017

Meseck M

4

1 reference

25 November 2017

Thung SN

5

1 reference

25 November 2017

Woo SL

6

1 reference

25 November 2017

1 June 2001

1 reference

Diabetes Research and Clinical Practice

25 November 2017

1 reference

25 November 2017

52

1 reference

25 November 2017

153-163

1 reference

25 November 2017

3

1 reference

The pathogenesis of insulin-dependent diabetes mellitus

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Insulin-dependent diabetes: a disease of autoaggression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Human ultralente insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Use of human ultralente as the basal insulin component in treatment of patients with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Glucokinase and glucose transporter expression in liver and islets: implications for control of glucose homoeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Transcriptional regulation by glucose in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Gene therapy for diabetes mellitus in rats by hepatic expression of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Glucagon and the A cell: physiology and pathophysiology (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Pharmacokinetics of continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Gene therapy for the hemophilias

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Glucose regulated production of human insulin in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900220-0

7 January 2021

10.1016/S0168-8227(01)00220-0

Identifiers

DOI

1 reference

release_s77sekiimrg57kmwi73dcndlj4

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s77sekiimrg57kmwi73dcndlj4

24 November 2022

mapped directly with Wikidata item

1 reference